Obesity Weekly News

Obesity Today—December 2, 2025

This week’s obesity update spotlights key developments, regulatory milestones,…


Obesity Weekly News

Obesity Today—November 25, 2025

This week’s obesity update brings you the latest clinical advancements,…


Obesity Weekly News

Obesity Today—November 18, 2025

Weekly Obesity update featuring major pipeline moves, regulatory and access…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal

Lucid Diligence Brief: ABL Bio and Eli Lilly Grabody-B license deal…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—November 10, 2025

This week’s AI in Healthcare and Digital Health brief distills AI-driven…


AHA 2025_Preview_by_LucidQuest

AHA 2025 Preview: Key Cardiovascular Highlights to Watch

AHA 2025 at a glance Get ready for AHA 2025 with LucidQuest’s concise preview.…


Endocrinology

Endocrinology Today — October 28, 2025

Endocrinology news this week covers major developments, updates, launches and…


Obesity Weekly News

Obesity Today — October 28, 2025

Catch the latest obesity news, featuring industry updates, clinical progress,…


Obesity Weekly News

Obesity Video Recap — October 28, 2025

Join us for this biweekly roundup of obesity news, where we summarize important…


Public_Health

Public Health Today - October 17, 2025

This week's public health update highlights major developments in disease…


Obesity Weekly News

Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)

This top obesity news video summary includes Chugai’s in-licensing of…


Obesity Weekly News

Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)

Obesity news this week include Chugai in-licensing Roche’s dual incretin CT-388…


Privacy Preference Center